IXC 1.41% 7.0¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-147

  1. 15,516 Posts.
    lightbulb Created with Sketch. 1280
    yep but that’s the issue at the moment. There is no need to rush to buy in as nothing of substance is happening for a while.

    I feel people who are interested will by closer to results. For now no one wants to sit on a share where in 2 years it could have 20% capital growth
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $5.261M
Open High Low Value Volume
7.1¢ 7.1¢ 7.0¢ $4.214K 59.36K

Buyers (Bids)

No. Vol. Price($)
1 198734 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 52542 1
View Market Depth
Last trade - 15.32pm 20/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.